← Open Payments lookup

KATELYNN CATALDO: Open Payments

NPI 1962836155 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,713 in 130 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,713

Food & beverage: $2,713
CompanyPaymentsAmount
Janssen Biotech, Inc.20$440
Takeda Pharmaceuticals U.S.A., Inc.20$360
Salix Pharmaceuticals, a division of Bausch Health US, LLC21$319
GENZYME CORPORATION7$197
Madrigal Pharmaceuticals6$197
Gilead Sciences, Inc.7$185
ABBVIE INC.13$181
Phathom Pharmaceuticals, Inc.7$164
Ipsen Biopharmaceuticals, Inc4$115
Ardelyx, Inc.6$103

Products named: TREMFYA, XIFAXAN, DUPIXENT, ENTYVIO, REZDIFFRA, VOQUEZNA, IQIRVO, IBSRELA.

Industry payments across MA — which companies pay providers there.